<DOC>
	<DOCNO>NCT00110422</DOCNO>
	<brief_summary>The purpose clinical research study learn irbesartan superior hydrochlorothiazide relative effect insulin sensitivity glucose metabolism hypertensive patient metabolic syndrome .</brief_summary>
	<brief_title>Irbesartan Treatment Hypertensive Patients With Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Subjects must willing able provide write informed consent . Subjects must read , sign , receive copy inform consent prior study procedure , include withdrawal antihypertensive medication . Males females &gt; = 18 year age . Uncontrolled hypertension define average systolic blood pressure &gt; = 140 mmHg and/or average diastolic blood pressure &gt; = 90 mmHg . This apply people take blood pressure medication people take one blood pressure medication . Presenting least 2 follow : Obesity ; High triglyceride ; Low HDL cholesterol ; Elevated fast glucose . Women child bear potential use adequate birth control . Women pregnant breastfeeding Diabetics Systolic blood pressure &gt; = 180 mmHg . Diastolic blood pressure &gt; = 110 mmHg . Stroke within past 12 month . Myocardial infarction heart revascularization procedure acute angina within past 6 month . Moderate severe heart failure . Significant kidney liver disease . Cancer past 5 year . Drug alcohol abuse . Gout Lupus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Metabolic Syndrome</keyword>
</DOC>